SQUAWK/NEWS
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

11 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-10-15 13:30 UTC

Intuit Shares Hit 4-week High

Intuit shares increased to 315.19 USD, the highest since September 2026. Over the past 4 weeks, Intuit lost 5.72%, and in the last 12 months, it decreased 52.44%.

News 2026-10-07 14:00 UTC

Intuitive Surgical Shares Hit 13-week High

Intuitive Surgical shares increased to 416.62 USD, the highest since July 2026. Over the past 4 weeks, Intuitive Surgical gained 18.8%, and in the last 12 months, it decreased 7.17%.

News 2026-10-07 12:58 UTC

Transcript: Constellation Brands Q2 2027 Earnings Conference Call

On Wednesday, Constellation Brands (NYSE: STZ ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Constellation Brands reported Q

News 2026-09-18 09:46 UTC

PubMatic Reports Q2 2026 Results: Full Earnings Call Transcript

On Thursday, PubMatic (NASDAQ: PUBM ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary PubMatic reported impressive financial results

News 2026-09-17 17:41 UTC

Intuitive Surgical Stock Price Hits 4-week High

Intuitive Surgical shares increased to 387.31 USD, the highest since August 2026. Over the past 4 weeks, Intuitive Surgical lost 1.02%, and in the last 12 months, it decreased 11.16%.

News 2026-07-17 11:41 UTC

Why Is Intuitive Surgical Stock Sinking Friday?

Intuitive Surgical Inc. (NASDAQ: ISRG ) stock fell more than 11% in Friday premarket trading after the robotic surgery company reported second-quarter results that topped Wall Street estimates but reaffirmed its procedure growth outlook. The company maintained its 2026 da Vinci procedure growth forecast but warned that